Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Guardant Health Inc (GH)

Guardant Health Inc (GH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,038,625
  • Shares Outstanding, K 94,383
  • Annual Sales, $ 214,380 K
  • Annual Income, $ -75,650 K
  • 60-Month Beta 0.65
  • Price/Sales 29.49
  • Price/Cash Flow N/A
  • Price/Book 7.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.39
  • Number of Estimates 3
  • High Estimate -0.36
  • Low Estimate -0.42
  • Prior Year -0.30
  • Growth Rate Est. (year over year) -30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.90 +18.07%
on 03/17/20
73.00 -9.59%
on 03/20/20
-12.13 (-15.53%)
since 03/06/20
3-Month
55.90 +18.07%
on 03/17/20
89.74 -26.45%
on 02/21/20
-13.49 (-16.97%)
since 01/08/20
52-Week
55.90 +18.07%
on 03/17/20
112.21 -41.18%
on 08/08/19
-0.15 (-0.23%)
since 04/08/19

Most Recent Stories

More News
Guardant Health (GH) Gains But Lags Market: What You Should Know

Guardant Health (GH) closed the most recent trading day at $65.84, moving +0.72% from the previous trading session.

GH : 65.73 (+2.74%)
Guardant Health (GH) in Focus: Stock Moves 6.5% Higher

Guardant Health (GH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

ACIU : 6.95 (+2.06%)
GH : 65.73 (+2.74%)
Horrible Week Finally Comes to an End

Horrible Week Finally Comes to an End

TQQQ : 53.96 (+5.39%)
CURE : 44.50 (+6.26%)
SGMO : 7.06 (+3.98%)
TTD : 206.60 (+7.98%)
JPM : 93.28 (+2.91%)
ACCO : 5.70 (+8.57%)
NTLA : 12.33 (+3.61%)
GH : 65.73 (+2.74%)
CRSP : 42.78 (+3.61%)
Intercept (ICPT) Q4 Earnings Miss, Revenues Beat Estimates

Intercept (ICPT) incurs wider loss in the fourth quarter while sales top mark. Shares fall probably as the action date for OCA's NDA to treat fibrosis due to NASH gets extended by the FDA.

RGEN : 95.95 (-0.72%)
ADRO : 2.66 (+6.83%)
ICPT : 66.41 (+5.56%)
GH : 65.73 (+2.74%)
Epizyme (EPZM) Q4 Earnings Miss Estimates, Revenues Beat

Epizyme (EPZM) reports wider-than-expected loss in the fourth quarter of 2019. Nonetheless, its sales beat estimates.

REGN : 499.43 (-0.41%)
ADRO : 2.66 (+6.83%)
EPZM : 16.72 (+11.10%)
GH : 65.73 (+2.74%)
Regeneron (REGN) Catches Eye: Stock Jumps 5.5%

Regeneron (REGN) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

REGN : 499.43 (-0.41%)
GH : 65.73 (+2.74%)
Zacks.com featured highlights include: Vista Outdoor, Guardant Health, Computer Programs and Systems, MicroStrategy and Sibanye Gold

Zacks.com featured highlights include: Vista Outdoor, Guardant Health, Computer Programs and Systems, MicroStrategy and Sibanye Gold

SBGL : 12.26 (-2.93%)
MSTR : 120.90 (+2.71%)
VSTO : 8.02 (+3.35%)
CPSI : 20.71 (+2.27%)
GH : 65.73 (+2.74%)
Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates

Guardant Health (GH) delivered earnings and revenue surprises of 10.00% and 15.42%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

GH : 65.73 (+2.74%)
Guardant Health: 4Q Earnings Snapshot

REDWOOD CITY, Calif. (AP) _ Guardant Health Inc. (GH) on Monday reported a loss of $22.1 million in its fourth quarter.

GH : 65.73 (+2.74%)
5 Low-Beta Stocks to Keep You Calm Despite Market Volatility

We have created a strategy which shows that securities involving low risk can also fetch impressive returns.

SBGL : 12.26 (-2.93%)
MSTR : 120.90 (+2.71%)
VSTO : 8.02 (+3.35%)
CPSI : 20.71 (+2.27%)
GH : 65.73 (+2.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade GH with:

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

2nd Resistance Point 71.46
1st Resistance Point 67.72
Last Price 65.73
1st Support Level 61.88
2nd Support Level 59.78

See More

52-Week High 112.21
Fibonacci 61.8% 90.70
Fibonacci 50% 84.06
Fibonacci 38.2% 77.41
Last Price 65.73
52-Week Low 55.90

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar